APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meningitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Meningitis Vaccine Industry Growth and Trends Forecast to 2032

26 December 202591 pages

Choose your research edition.

Industry ResearchMeningitis Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Meningitis Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Meningitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meningitis Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Meningitis Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Meningitis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meningitis Vaccine include Zhejiang Tianyuan, Sanofi Pasteur, Novartis, Merck, Pfizer, GlaxoSmithKline, Beijing Tiantan Biological, Baxter International and Hualan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Meningitis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Meningitis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Meningitis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Meningitis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Meningitis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Meningitis Vaccine Market by Company

Zhejiang Tianyuan

Sanofi Pasteur

Novartis

Merck

Pfizer

GlaxoSmithKline

Beijing Tiantan Biological

Baxter International

Hualan

Meningitis Vaccine Segment by Type

Meningitis A+C

Meningitis ACWY135

Meningitis B

Meningitis Vaccine Segment by Application

Medical Care

Hospital

Meningitis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meningitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meningitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Meningitis A+C Table 2. Major Company of Meningitis ACWY135 Table 3. Major Company of Meningitis B Table 4. Global Meningitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Meningitis Vaccine Sales by Type (2021-2026) & (W Tons) Table 6. Global Meningitis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Meningitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Meningitis Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Meningitis Vaccine Price by Type (2021-2026) & (US$/Ton) Table 10. Global Meningitis Vaccine Sales by Type (2027-2032) & (W Tons) Table 11. Global Meningitis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Meningitis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Meningitis Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Meningitis Vaccine Price by Type (2027-2032) & (US$/Ton) Table 15. North America Meningitis Vaccine Sales by Type (2021-2026) & (W Tons) Table 16. North America Meningitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Meningitis Vaccine Sales by Type (2021-2026) & (W Tons) Table 18. Europe Meningitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Meningitis Vaccine Sales by Type (2021-2026) & (W Tons) Table 20. Asia-Pacific Meningitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Meningitis Vaccine Sales by Type (2021-2026) & (W Tons) Table 22. Latin America Meningitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Meningitis Vaccine Sales by Type (2021-2026) & (W Tons) Table 24. Middle East and Africa Meningitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Meningitis Vaccine Industry Trends Table 26. Meningitis Vaccine Industry Drivers Table 27. Meningitis Vaccine Industry Opportunities and Challenges Table 28. Meningitis Vaccine Industry Restraints Table 29. Global Meningitis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Meningitis Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Meningitis Vaccine Sales by Company (2021-2026) & (W Tons) Table 32. Global Meningitis Vaccine Sales Share by Company (2021-2026) Table 33. Global Meningitis Vaccine Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Meningitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Meningitis Vaccine Major Company Production Sites and Headquarters Table 36. Global Meningitis Vaccine Company, Product Type & Application Table 37. Global Meningitis Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Meningitis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Meningitis Vaccine Sales by Region (2021-2026) & (W Tons) Table 42. Global Meningitis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Meningitis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Meningitis Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Meningitis Vaccine Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Meningitis Vaccine Sales by Region (2027-2032) & (W Tons) Table 47. Global Meningitis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Meningitis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Meningitis Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Meningitis Vaccine Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Meningitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Meningitis Vaccine Sales by Application (2021-2026) & (W Tons) Table 53. Global Meningitis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Meningitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Meningitis Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Meningitis Vaccine Price by Application (2021-2026) & (US$/Ton) Table 57. Global Meningitis Vaccine Sales by Application (2027-2032) & (W Tons) Table 58. Global Meningitis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Meningitis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Meningitis Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Meningitis Vaccine Price by Application (2027-2032) & (US$/Ton) Table 62. North America Meningitis Vaccine Sales by Application (2021-2026) & (W Tons) Table 63. North America Meningitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Meningitis Vaccine Sales by Application (2021-2026) & (W Tons) Table 65. Europe Meningitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Meningitis Vaccine Sales by Application (2021-2026) & (W Tons) Table 67. Asia-Pacific Meningitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Meningitis Vaccine Sales by Application (2021-2026) & (W Tons) Table 69. Latin America Meningitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Meningitis Vaccine Sales by Application (2021-2026) & (W Tons) Table 71. Middle East and Africa Meningitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Zhejiang Tianyuan Company Information Table 73. Zhejiang Tianyuan Business Overview Table 74. Zhejiang Tianyuan Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Zhejiang Tianyuan Meningitis Vaccine Product Portfolio Table 76. Zhejiang Tianyuan Recent Development Table 77. Sanofi Pasteur Company Information Table 78. Sanofi Pasteur Business Overview Table 79. Sanofi Pasteur Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Sanofi Pasteur Meningitis Vaccine Product Portfolio Table 81. Sanofi Pasteur Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Novartis Meningitis Vaccine Product Portfolio Table 86. Novartis Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Merck Meningitis Vaccine Product Portfolio Table 91. Merck Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Pfizer Meningitis Vaccine Product Portfolio Table 96. Pfizer Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Meningitis Vaccine Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Beijing Tiantan Biological Company Information Table 103. Beijing Tiantan Biological Business Overview Table 104. Beijing Tiantan Biological Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Beijing Tiantan Biological Meningitis Vaccine Product Portfolio Table 106. Beijing Tiantan Biological Recent Development Table 107. Baxter International Company Information Table 108. Baxter International Business Overview Table 109. Baxter International Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Baxter International Meningitis Vaccine Product Portfolio Table 111. Baxter International Recent Development Table 112. Hualan Company Information Table 113. Hualan Business Overview Table 114. Hualan Meningitis Vaccine Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Hualan Meningitis Vaccine Product Portfolio Table 116. Hualan Recent Development Table 117. North America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 118. North America Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 119. North America Meningitis Vaccine Sales Market Share by Country (2021-2026) Table 120. North America Meningitis Vaccine Sales Forecast by Country (2027-2032) & (W Tons) Table 121. North America Meningitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 122. North America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Meningitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Meningitis Vaccine Market Share by Country (2021-2026) Table 125. North America Meningitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Meningitis Vaccine Market Share Forecast by Country (2027-2032) Table 127. Europe Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 128. Europe Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 129. Europe Meningitis Vaccine Sales Market Share by Country (2021-2026) Table 130. Europe Meningitis Vaccine Sales Forecast by Country (2027-2032) & (W Tons) Table 131. Europe Meningitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Meningitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Meningitis Vaccine Market Share by Country (2021-2026) Table 135. Europe Meningitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Meningitis Vaccine Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 139. Asia-Pacific Meningitis Vaccine Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Meningitis Vaccine Sales Forecast by Country (2027-2032) & (W Tons) Table 141. Asia-Pacific Meningitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Meningitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Meningitis Vaccine Market Share by Country (2021-2026) Table 145. Asia-Pacific Meningitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Meningitis Vaccine Market Share Forecast by Country (2027-2032) Table 147. Latin America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 148. Latin America Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 149. Latin America Meningitis Vaccine Sales Market Share by Country (2021-2026) Table 150. Latin America Meningitis Vaccine Sales Forecast by Country (2027-2032) & (W Tons) Table 151. Latin America Meningitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Meningitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Meningitis Vaccine Market Share by Country (2021-2026) Table 155. Latin America Meningitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Meningitis Vaccine Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 159. Middle East and Africa Meningitis Vaccine Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Meningitis Vaccine Sales Forecast by Country (2027-2032) & (W Tons) Table 161. Middle East and Africa Meningitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Meningitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Meningitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Meningitis Vaccine Market Share by Country (2021-2026) Table 165. Middle East and Africa Meningitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Meningitis Vaccine Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Meningitis Vaccine Distributors List Table 170. Meningitis Vaccine Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Meningitis Vaccine Image Figure 2. Global Meningitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meningitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Meningitis Vaccine Sales (2021-2032) & (W Tons) Figure 5. Meningitis A+C Image Figure 6. Global Meningitis A+C Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Meningitis ACWY135 Image Figure 8. Global Meningitis ACWY135 Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Meningitis B Image Figure 10. Global Meningitis B Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Global Meningitis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Meningitis Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Meningitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Meningitis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Meningitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Meningitis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Meningitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Meningitis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Meningitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Meningitis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Meningitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Meningitis Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Meningitis Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Medical Care Image Figure 26. Global Medical Care Sales YoY Growth (2021-2032) & (W Tons) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (W Tons) Figure 29. Global Meningitis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Meningitis Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Meningitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Meningitis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Meningitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Meningitis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Meningitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Meningitis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Meningitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Meningitis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Meningitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Meningitis Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Meningitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 42. North America Meningitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Meningitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Meningitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 46. Europe Meningitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Meningitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Meningitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 50. Asia-Pacific Meningitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Meningitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Meningitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 54. Latin America Meningitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Meningitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Meningitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 58. Middle East and Africa Meningitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Meningitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Meningitis Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Meningitis Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Meningitis A+C
  • Meningitis ACWY135
  • Meningitis B
Applications
  • Medical Care
  • Hospital
Companies covered
  • Zhejiang Tianyuan
  • Sanofi Pasteur
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Beijing Tiantan Biological
  • Baxter International
  • Hualan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Meningitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Meningitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Meningitis Vaccine Market by Type
  6. 1.3.1 Meningitis A+C
  7. 1.3.2 Meningitis ACWY135
  8. 1.3.3 Meningitis B
  9. 1.4 Global Meningitis Vaccine Market Size by Type
  10. 1.4.1 Global Meningitis Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Meningitis Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Meningitis Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Meningitis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Meningitis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Meningitis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Meningitis Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Meningitis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Meningitis Vaccine Industry Trends
  2. 2.2 Meningitis Vaccine Industry Drivers
  3. 2.3 Meningitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Meningitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Meningitis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Meningitis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Meningitis Vaccine Price (2021-2026)
  4. 3.4 Global Meningitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meningitis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Meningitis Vaccine Company, Product Type & Application
  7. 3.7 Global Meningitis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meningitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meningitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meningitis Vaccine Tier 1, Tier 2, and Tier 3
4 Meningitis Vaccine Regional Status and Outlook
  1. 4.1 Global Meningitis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Meningitis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Meningitis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Meningitis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Meningitis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Meningitis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Meningitis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Meningitis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Meningitis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Meningitis Vaccine by Application
  1. 5.1 Meningitis Vaccine Market by Application
  2. 5.1.1 Medical Care
  3. 5.1.2 Hospital
  4. 5.2 Global Meningitis Vaccine Market Size by Application
  5. 5.2.1 Global Meningitis Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Meningitis Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Meningitis Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Meningitis Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Meningitis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Meningitis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Meningitis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Meningitis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Tianyuan
  2. 6.1.1 Zhejiang Tianyuan Company Information
  3. 6.1.2 Zhejiang Tianyuan Business Overview
  4. 6.1.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Tianyuan Meningitis Vaccine Product Portfolio
  6. 6.1.5 Zhejiang Tianyuan Recent Developments
  7. 6.2 Sanofi Pasteur
  8. 6.2.1 Sanofi Pasteur Company Information
  9. 6.2.2 Sanofi Pasteur Business Overview
  10. 6.2.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Pasteur Meningitis Vaccine Product Portfolio
  12. 6.2.5 Sanofi Pasteur Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Meningitis Vaccine Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Meningitis Vaccine Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Meningitis Vaccine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Meningitis Vaccine Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Beijing Tiantan Biological
  38. 6.7.1 Beijing Tiantan Biological Company Information
  39. 6.7.2 Beijing Tiantan Biological Business Overview
  40. 6.7.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Tiantan Biological Meningitis Vaccine Product Portfolio
  42. 6.7.5 Beijing Tiantan Biological Recent Developments
  43. 6.8 Baxter International
  44. 6.8.1 Baxter International Company Information
  45. 6.8.2 Baxter International Business Overview
  46. 6.8.3 Baxter International Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Baxter International Meningitis Vaccine Product Portfolio
  48. 6.8.5 Baxter International Recent Developments
  49. 6.9 Hualan
  50. 6.9.1 Hualan Company Information
  51. 6.9.2 Hualan Business Overview
  52. 6.9.3 Hualan Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hualan Meningitis Vaccine Product Portfolio
  54. 6.9.5 Hualan Recent Developments
7 North America by Country
  1. 7.1 North America Meningitis Vaccine Sales by Country
  2. 7.1.1 North America Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Meningitis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Meningitis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Meningitis Vaccine Market Size by Country
  6. 7.2.1 North America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Meningitis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Meningitis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Meningitis Vaccine Sales by Country
  2. 8.1.1 Europe Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Meningitis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Meningitis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Meningitis Vaccine Market Size by Country
  6. 8.2.1 Europe Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Meningitis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Meningitis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Meningitis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Meningitis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Meningitis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Meningitis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Meningitis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Meningitis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Meningitis Vaccine Sales by Country
  2. 10.1.1 South America Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Meningitis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Meningitis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Meningitis Vaccine Market Size by Country
  6. 10.2.1 South America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Meningitis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Meningitis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Meningitis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Meningitis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Meningitis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Meningitis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Meningitis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Meningitis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Meningitis Vaccine Value Chain Analysis
  2. 12.1.1 Meningitis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Meningitis Vaccine Production Mode & Process
  7. 12.2 Meningitis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Meningitis Vaccine Distributors
  10. 12.2.3 Meningitis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst